ClinicalTrials HQ

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Recruiting · NCT06976268 · Registry updated 2026-09-28
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseaseParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingPhase 2 / Phase 32026-09-28NCT06976268

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Biohaven Therapeutics Ltd.13

24 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site-003IrvineUnited States1
Site-004FoxboroughUnited States1
Site-005New YorkUnited States1
Site-006AlbanyUnited States1
Site-007BellevueUnited States1
Site-009HenricoUnited States1
Site-015Farmington HillsUnited States1
Site-017Boca RatonUnited States1
Site-019SeattleUnited States1
Site-025AuroraUnited States1
Site-027ChicagoUnited States1
Site-028New HavenUnited States1
Site-029Kansas CityUnited States1
Site-031FarmingtonUnited States1
Site-038AtlantisUnited States1
Site-041Los AngelesUnited States1
Site-043Round RockUnited States1
Site-044ChesterfieldUnited States1
Site-049BirminghamUnited States1
Site-051MaitlandUnited States1
Site-071BostonUnited States1
Site-074Newport NewsUnited States1
Site-082ClevelandUnited States1
Site-091PortlandUnited States1